EuBiologics Co., Ltd. (KOSDAQ: 206650)
South Korea
· Delayed Price · Currency is KRW
12,130
-450 (-3.58%)
Dec 19, 2024, 9:00 AM KST
EuBiologics Revenue
In the year 2023, EuBiologics had annual revenue of 69.37B KRW with 25.06% growth. EuBiologics had revenue of 26.89B in the quarter ending December 31, 2023, with 54.38% growth.
Revenue
69.37B
Revenue Growth
+25.06%
P/S Ratio
6.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
433.66B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 69.37B | 13.90B | 25.06% |
Dec 31, 2022 | 55.47B | 16.08B | 40.83% |
Dec 31, 2021 | 39.38B | 10.90B | 38.24% |
Dec 31, 2020 | 28.49B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition